Insider Cluster (2 insiders) ·Filed Jun 2, 2026

MDWD

MediWound Ltd.
BULLISH
Impact 4/10
Horizonweeks Processed4mo ago
Insider cluster: 2 insiders, $27K total
Actionable Insight ▲ Bullish

The cluster of director purchases, while small in absolute terms, is a rare bullish insider signal for MDWD. Monitor for upcoming catalysts (earnings, NexoBrid milestones) that may have prompted the buying. The 92% analyst bullish consensus suggests the market is already optimistic, so the signal is confirmatory rather than transformative.

DirectionBullish
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d
MDWD ▼ -7.70% at T+60d
LONG call ✗ call lost -7.70% · α vs SPY -8.82% · entry $13.76 → $12.70
Entry anchored
Jun 1, 03:59 PM ET
via exchange tick
T+1d
-0.22%
call -0.22% · α +0.48%
$13.73
settled 4mo ago
T+5d
+3.92%
call +3.92% · α +6.89%
$14.30
settled 4mo ago
T+20d
+7.70%
call +7.70% · α +9.27%
$14.82
settled 3mo ago
T+60d
-7.70%
call -7.70% · α -8.82%
$12.70
settled 5w ago

Price Chart

Loading chart...

Executive Summary

Two MediWound directors made open-market purchases totaling $27K over a 4-day window. While the dollar amount is small relative to the $178M market cap (0.015%), cluster buys by directors are a modestly positive signal, especially given the company's 92% analyst bullish consensus.

Key Financial Metrics

Direction
buying
Total Value
$26.8K
Insiders
2

Key Facts

  • Director David Morton Fox purchased 1,730 shares at $14.225 on June 1, 2026, for ~$24.6K.
  • Director Samuel Rubinstein purchased 150 shares at $14.33 on May 29, 2026, for ~$2.1K.
  • Total insider buying: $26.8K, representing ~0.015% of market cap.
  • Both transactions were open-market purchases (code P), not grants or exercises.
  • No insider sales were reported in the same window.

Financial Impact

Total insider purchases of $26.8K, negligible relative to $178M market cap.

Risk Factors

  • Purchase amounts are very small relative to market cap, limiting signal strength.
  • Directors may be buying for diversification or personal reasons, not informational edge.
  • Historical calibration shows cluster buys at this score level have only 31% win rate at T+20.

Market Snapshot

Exchange
Nasdaq
Sector
Medicinal Chemicals & Botanical Products
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-MDWD-1780399845353
6 reports for MDWD
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for MDWD — sortable, filterable
TypeNow
Jun 2, 2026
17w ago
Insider Cluster
BULLISH ★ 4/10
$13.76 $12.70▼ −7.70%▼ −8.82%$13.52 (−1.74%)
May 27, 2026
18w ago
Press Release
BEARISH ★ 6/10
$14.33 $13.12▲ +8.48%▲ +10.36%$13.52 (+5.65%)
May 7, 2026
21w ago
Press Release
NEUTRAL ★ 2/10
$17.27 $14.22▼ −17.66%▼ −21.49%$13.52 (−21.71%)
Mar 30, 2026
26w ago
6-K
NEUTRAL ★ 2/10
$16.11 $15.19▼ −5.71%▼ −18.09%$13.52 (−16.08%)
Mar 5, 2026
30w ago
Press Release
NEUTRAL ★ 3/10
$17.03 $13.82▼ −18.85%▼ −31.63%$13.52 (−20.61%)
Mar 5, 2026
30w ago
Press Release
BEARISH ★ 6/10
$17.45 $13.82▲ +20.80%▲ +32.10%$13.52 (+22.52%)
Showing 6 of 6

US Market Status

Market Closed — Opens Mon (38h 34m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 2, 2026